Effect of Blue Light-Filtering Intraocular Lenses Nationwide Cohort Study With 10-Year Follow-up

被引:5
作者
See, Lai-Chu [1 ,2 ,3 ]
Li, Pei-Ru [1 ]
Lin, Ken-Kuo [4 ,5 ]
Hou, Chiun-Ho [4 ,5 ]
Lee, Jiahn-Shing [4 ,5 ,6 ]
机构
[1] Chang Gung Univ, Sch Med, Dept Publ Hlth, Taoyuan City, Taiwan
[2] Chang Gung Mem Hosp Linkou, Div Rheumatol Allergy & Immunol, Taoyuan City, Taiwan
[3] Chang Gung Univ, Mol Med Res Ctr, Biostat Core Lab, Taoyuan City, Taiwan
[4] Chang Gung Mem Hosp Linkou, Dept Ophthalmol, Taoyuan City, Taiwan
[5] Chang Gung Univ, Sch Med, Dept Med, Taoyuan City, Taiwan
[6] Chang Gung Mem Hosp Linkou, Dept Ophthalmol, 5 Fusing St, Taoyuan City 33305, Taiwan
关键词
PROPENSITY SCORE METHODS; CIRCADIAN PHOTOENTRAINMENT; CATARACT-SURGERY; BLOCKING; INSOMNIA; SLEEP; MELATONIN; RISK; ULTRAVIOLET;
D O I
10.1016/j.ajo.2022.01.012
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE: To compare the incidence of clinically diagnosed insomnia after cataract surgery in pseudophakic eyes with blue light-filtering intraocular lenses (BFIOLs) and non-BF-IOLs. DESIGN: Nationwide cohort study using the Taiwan National Health Insurance Research Database. METHODS: We enrolled 171,415 patients who underwent cataract surgery in both eyes between 2008 and 2013 and followed them till 2018. Propensity score matching (PSM) was used to balance the baseline characteristics between the 2 IOL groups. The Cox model and cause-specific hazard model were used to estimate the hazard ratios (HRs) and subdistribution hazard ratio (SHR). RESULTS: Overall, 19,604 (11.4%) and 151,811 (88.6%) patients had BF-IOL and non-BF-IOL implants, respectively. The BF-IOL group tended to be younger and had fewer chronic diseases. Within a mean follow-up period of 6.2 years, the incidence rates of insomnia (per 100 person-years) in the BF-IOL and non-BF-IOL groups were 2.97 and 3.21, respectively. There was no significant difference in the incidence rate of insomnia between the 2 IOL groups after treating all-cause mortality as a competing risk (SHR 0.98, 95% CI 0.95-1.01) and after PSM (HR 0.97, 95% CI 0.92-1.01), respectively. Subgroup analysis revealed no significant difference in the insomnia rate between the 2 IOL groups for various age groups, 2 sex groups, and men with and without benign prostatic hyperplasia. CONCLUSION: In Taiwan, the use of a BF-IOL for up to 10 years had no apparent disadvantage over non BF-IOLs with respect to insomnia. ((C) 2022 Elsevier Inc. All rights reserved.)
引用
收藏
页码:26 / 36
页数:11
相关论文
共 48 条